Celastrol alleviates SGLT2 inhibitor-induced diabetic hyperketonemia by inhibiting hepatic ketogenesis
Yinghan Zhu, Yiting Wang, Minglong Zhang, Lingxu Liu, Yang Tian, Zeyu Guo, Ran Zhang, Jinrui Zhang, Zhenyu Ma, 方福德, Li Yan, Xiaojun Liu
Celastrol reduces SGLT2 inhibitor-induced hyperketonemia by inhibiting hepatic ketogenesis through PPAR-dependent mechanisms.
Acta Biochimica et Biophysica Sinica · Sep 15, 2026Peer-reviewedMolecular Biology